Advances of Targeted Therapy in Treatment of Unresectable Metastatic Colorectal Cancer - Wikidata - awgldk - TriplyDB

Advances of Targeted Therapy in Treatment of Unresectable Metastatic Colorectal Cancer

Advances of Targeted Therapy in Treatment of Unresectable Metastatic Colorectal Cancer

http://www.wikidata.org/entity/Q26748924

about

Colorectal Cancer: From the Genetic Model to Posttranscriptional Regulation by Noncoding RNAs.Novel proapoptotic agent SM-1 enhances the inhibitory effect of 5-fluorouracil on colorectal cancer cells in vitro and in vivo Reactive Oxygen Species-Mediated Mechanisms of Action of Targeted Cancer Therapy Non-Coding RNAs as Predictive Biomarkers to Current Treatment in Metastatic Colorectal Cancer.Traditional Chinese medicine Danggui Buxue Tang inhibits colorectal cancer growth through induction of autophagic cell death.

P2860

Q33720978-49D0FE0E-F27C-42FC-BDB9-BC70EA7412C3 Q33751056-73BCFA20-53A8-4E08-B100-17C3623A7CBF Q33862425-C6AF0D57-3F4F-46EF-8716-AE672C824642 Q39438832-67DC824A-959F-47B6-9BB0-60DC04C95AA9 Q47098816-3C783318-2413-4177-9573-EFD6ACC389CD

P2860

Advances of Targeted Therapy in Treatment of Unresectable Metastatic Colorectal Cancer

http://www.wikidata.org/entity/Q26748924

description

2016 nî lūn-bûn

@nan

2016 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Advances of Targeted Therapy in Treatment of Unresectable Metastatic Colorectal Cancer

@ast

Advances of Targeted Therapy in Treatment of Unresectable Metastatic Colorectal Cancer

@en

Advances of Targeted Therapy in Treatment of Unresectable Metastatic Colorectal Cancer

@nl

type

label

Advances of Targeted Therapy in Treatment of Unresectable Metastatic Colorectal Cancer

@ast

Advances of Targeted Therapy in Treatment of Unresectable Metastatic Colorectal Cancer

@en

Advances of Targeted Therapy in Treatment of Unresectable Metastatic Colorectal Cancer

@nl

prefLabel

Advances of Targeted Therapy in Treatment of Unresectable Metastatic Colorectal Cancer

@ast

Advances of Targeted Therapy in Treatment of Unresectable Metastatic Colorectal Cancer

@en

Advances of Targeted Therapy in Treatment of Unresectable Metastatic Colorectal Cancer

@nl

P1433

Q26748924-35B90D66-E6D7-49A3-A97E-929E91A701F0

P1476

Q26748924-3BC7C022-6893-4E53-83B3-1E6CDB2815BE

P2093

Q26748924-78105D49-4009-41FB-B381-4D03834746FD

Q26748924-82DBEF0A-1227-4ABB-97FB-0AFF19802938

P275

Q26748924-4E24DD64-12C0-4D75-AEC3-88D0CB097BCE

P2860

Q26748924-021A78D4-0A3A-42A8-AD31-0BC9FDDE0C1C

Q26748924-03703C28-21EC-4DEC-977B-630D296DA4FD

Q26748924-04684C3D-4B84-4212-A0A7-5914CC622849

Q26748924-0590A55C-96FC-487C-9064-79D107337DC6

Q26748924-06496260-1CFE-4961-84D9-38331B338413

Q26748924-075E840E-D6B7-4120-8E2D-6ADE7923A0E6

Q26748924-07DA4EFB-8DBA-47C1-B7AE-AF908D5B9FE9

Q26748924-09A401C4-6380-4D78-AFDD-D44A29DC038C

Q26748924-0D718395-CD0E-47EE-A306-4DBDACF03910

Q26748924-1316804D-9BE5-4105-8AE2-AD49159973E4

P304

Q26748924-157BDD00-E497-44DE-A331-37647B9ED7DC

P31

Q26748924-5FC59967-049D-4E5B-8663-ACB00B9698B9

Q26748924-94D18CC8-241C-4BC7-9E76-658B5DFEBB6D

P3181

Q26748924-41045C11-1A6F-4F2F-8342-DBD13C6B9C6B

P356

Q26748924-5167F5B6-1172-41A3-8AD8-FB8C4F1EC769

P407

Q26748924-2AC68AF6-CCD1-4691-AAB1-BE6B69AFD85B

P478

Q26748924-E0549BEF-6525-494F-A40B-9BBF608FE28F

P5008

Q26748924-CAB5B80C-29EA-4A3B-9657-29189777B834

P577

Q26748924-E07FBDEC-989B-4F12-B102-83D2B0FF51E0

P5875

Q26748924-1E70BE5B-7AAB-4172-AFA5-4BF407BB886B

P698

Q26748924-CC8B17D9-504A-4BC4-9E39-89264AA306DC

P921

Q26748924-5AD4D861-5A1B-4B32-89FD-7AC22711C154

P932

Q26748924-F8215D09-C99D-48B4-8B4C-682ABD1362DA

P3181

P356

P1433

BioMed Research International

P1476

Advances of Targeted Therapy in Treatment of Unresectable Metastatic Colorectal Cancer

@en

P2093

Sang Cheul Oh

http://www.w3.org/2001/XMLSchema#string

Suk-Young Lee

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

Amplification of the MET receptor drives resistance to anti-EGFR therapies in colorectal cancer

Activation of ERBB2 signaling causes resistance to the EGFR-directed therapeutic antibody cetuximab

Addition of bevacizumab to first-line chemotherapy in advanced colorectal cancer: a systematic review and meta-analysis, with emphasis on chemotherapy subgroups

Phase II trial of cetuximab in patients with refractory colorectal cancer that expresses the epidermal growth factor receptor.

Open-label phase III trial of panitumumab plus best supportive care compared with best supportive care alone in patients with chemotherapy-refractory metastatic colorectal cancer.

Cetuximab for the treatment of colorectal cancer.

KRAS mutations as an independent prognostic factor in patients with advanced colorectal cancer treated with cetuximab.

K-ras mutations and benefit from cetuximab in advanced colorectal cancer.

Wild-type BRAF is required for response to panitumumab or cetuximab in metastatic colorectal cancer.

Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis.

P304

7590245

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2468307

http://www.w3.org/2001/XMLSchema#string

P356

10.1155/2016/7590245

http://www.w3.org/2001/XMLSchema#string

P407

P478

2016

http://www.w3.org/2001/XMLSchema#string

P5008

P577

2016-04-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

301240553

http://www.w3.org/2001/XMLSchema#string

P698

27127793

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer

P932

4835624

http://www.w3.org/2001/XMLSchema#string